TransCanada to File Energy East Pipeline Project

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
TransCanada to File Energy East Pipeline Project Application with National Energy Board of Canada

TORONTO, ONTARIO and QUÉBEC CITY, QUÉBEC--(Marketwired - Oct. 29, 2014) - TransCanada (TSX:TRP) (NYSE:TRP) plans to file its application for the proposed Energy East Pipeline Project with the National Energy Board of Canada on Thursday, October 30, 2014. A simultaneous news conference in Toronto and Québec City will take place tomorrow to provide an update on the project and discuss the application that is considered to be one of the most comprehensive regulatory documents in the company's history.

For media not in attendance, web and telephone conferencing will be available for the conferences with an opportunity for media to ask questions over the phone. Please see details below. The news conferences will be linked via video conferencing in both French and English languages. Speakers will be available directly afterward for follow up interviews.

Date: Thursday, October 30, 2014
Time: 8:30 a.m. (MST) 10:30 a.m. (EST)
Location 1: Toronto:
Metro Toronto Convention Centre - Room 203 A-D
255 Front Street West, Toronto
Russ Girling
President and Chief Executive Officer, TransCanada
Alex Pourbaix
Executive Vice-President and President of Development,
TransCanada
Location 2: Québec City:
Hilton Québec - Les Plaines Lounge
1100 Rene Levesque East, Québec City
Francois Poirier
President, Energy East Pipeline Project
John Van der Put
Vice-President, Québec and New Brunswick, Energy East Pipeline Project
Philippe Cannon
Director, Québec, Energy East Pipeline Project
Dial-In: To access the live English webcast (live audio and video) of the news conference visit: http://www.gowebcasting.com/5877
For questions, media can dial-in at: 416-695-7806 or 1-888-789-9572
Pass code: 6841062
To access the live French webcast (live audio and video) of the news conference visit: http://www.gowebcasting.com/5878
For questions, media can dial-in at: 416-695-7806 or 1-888-789-9572
Pass code: 9854058
Other: Audio-visual equipment is located on-site and a media feed will be available for those in attendance.
Media: Accredited media welcome. May be asked to show credentials.

ABOUT TRANSCANADA

With more than 60 years' experience, TransCanada is a leader in the responsible development and reliable operation of North American energy infrastructure including natural gas and liquids pipelines, power generation and gas storage facilities. TransCanada operates a network of natural gas pipelines that extends more than 68,500 kilometres (42,500 miles), tapping into virtually all major gas supply basins in North America. TransCanada is one of the continent's largest providers of gas storage and related services with more than 400 billion cubic feet of storage capacity. A growing independent power producer, TransCanada owns or has interests in over 11,800 megawatts of power generation in Canada and the United States. TransCanada is developing one of North America's largest liquids delivery systems. TransCanada's common shares trade on the Toronto and New York stock exchanges under the symbol TRP. Visit TransCanada.com and our blog to learn more, or follow us on social media and 3BL Media .

FORWARD LOOKING INFORMATION

This publication contains certain information that is forward-looking and is subject to important risks and uncertainties (such statements are usually accompanied by words such as "anticipate", "expect", "believe", "may", "will", "should", "estimate", "intend" or other similar words). Forward-looking statements in this document are intended to provide TransCanada security holders and potential investors with information regarding TransCanada and its subsidiaries, including management's assessment of TransCanada's and its subsidiaries' future plans and financial outlook. All forward-looking statements reflect TransCanada's beliefs and assumptions based on information available at the time the statements were made and as such are not guarantees of future performance. Readers are cautioned not to place undue reliance on this forward-looking information, which is given as of the date it is expressed in this news release, and not to use future-oriented information or financial outlooks for anything other than their intended purpose. TransCanada undertakes no obligation to update or revise any forward-looking information except as required by law. For additional information on the assumptions made, and the risks and uncertainties which could cause actual results to differ from the anticipated results, refer to the Quarterly Report to Shareholders dated July 31, 2014 and 2013 Annual Report filed under TransCanada's profile on SEDAR at www.sedar.com and with the U.S. Securities and Exchange Commission at www.sec.gov .

TransCanada Media Enquiries: Shawn Howard/Mark Cooper/Philippe Cannon (Montreal) 403.920.7859 or 800.608.7859 TransCanada Investor & Analyst Enquiries: David Moneta/Lee Evans 403.920.7911 or 800.361.6522
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Leqembi Pen Revolutionizes Alzheimer's Care in Japan

Updated Category News Views 22

Innovative Alzheimer's Treatment Hits Japanese Market Just when you think the medical world needs a jolt of innovation, BioArctic rolls out something that could change how Alzheimer's is managed. With their subcutaneous Leqembi Pen, they've just added another feather in their cap, launching in Japan after a successful U.S. introduction. Not just your run-of-the-mill...

Continue Reading
Randi Baptiste Sets a New Standard in Youth Sports

Updated Category News Views 62

Youth Sports: Revolutionized by Randi Baptiste In an era where youth sports face a minefield of health risks and performance pressures, Randi Baptiste stands out. This isn't just about running around the park—this is about fundamentally transforming how we think about athletic development for young folks. Recognizing Baptiste for his contributions, The Inner Circle...

Continue Reading
Simform's AI Innovations Earns Microsoft Award Nod

Updated Category News Views 64

Riding the AI Wave with Simform In the chaotic world of AI and tech partnerships, earning recognition from a powerhouse like Microsoft ain't your run-of-the-mill achievement. Simform being recognized as a finalist for the 2026 Microsoft Innovate with Azure AI Apps and Agents Partner of the Year Award is a big deal, not just for them, but as a beacon of inspiration for...

Continue Reading
GAC's Green Push Unveils 3rd Showroom in Casablanca

Updated Category News Views 146

Pushing Through North Africa's Automotive Shift Well, looks like GAC is showing they're not just dabbling in North Africa—they're planting some sturdy roots in that rocky soil. Opening their third showroom in Casablanca, GAC isn't just settling for sidelines. They're step-in-the-ring serious about carving their name on North African roads. This isn't some skin-deep...

Continue Reading
Adam Foundation's Ramadan Effort to Cut Plastic Waste

Updated Category News Views 27

Environmental Consciousness: A Call from Antalya Here we go again, folks. Something refreshing is brewing over in Antalya at COP31, where the UK-based Adam Foundation has made a move that resonates beyond the usual hubbub. No smoke and mirrors, just straightforward action aimed at cutting down the wave of plastic waste during Ramadan. This isn't some pie-in-the-sky green...

Continue Reading
FF EAI Robotics Aims for Top Spot in K-12 Tech

Updated Category News Views 28

FFR's Shot at Robotics Education Dominance You ever feel like a company is throwing everything but the kitchen sink at an opportunity? That's FF EAI Robotics for you—charging ahead with a hefty laundry list of tech ambitions. They've clocked in about $2.3 million in revenue from their newly acquired robotics wing for the first nine months of 2026, showing a 26% gross...

Continue Reading
Rethinking Risk: AI, Cyber, and Ops Convergence

Updated Category News Views 28

Risk Management's New Frontier Hold onto your hats, folks, because the landscape of risk management is shifting under our feet—and not a minute too soon. With AI adoption skyrocketing, cybersecurity threats piling up like never-ending junk mail, and operational hurdles lurking around every corner, Wipfli's throwing down the gauntlet for business leaders to wise up....

Continue Reading
Implantica's Q3 2026: A Potential Leap Forward?

Updated Category News Views 34

Implantica Prepares to Unveil Q3 Results We're heading into the home stretch for 2026, and Implantica's about to unveil its third-quarter results. With its presentation scheduled for November 19 at 15:00 CET, this medtech outfit has caught some eyes, especially with their flagship offering, RefluxStop®. Paying attention here might be worthwhile, as this plays into a...

Continue Reading
Squeez and Qentelli Join Forces to Revolutionize Loyalty

Updated Category News Views 438

A New Era of Loyalty Commerce The winds are changing in the loyalty game, and it's about time someone shook things up. Squeez has teamed up with Qentelli, thanks to a $1 million investment, to kick-start this next wave of commerce. And boy, it's not just about money—it's like combining brains with brawn. Squeez isn't just offering loyalty programs anymore; they're...

Continue Reading
Vipshop Sets 2026 AGM: Shareholders Meet on Dec 8

Updated Category News Views 21

Blockbuster or Bust: Vipshop's Upcoming AGM Here's the scoop: Vipshop Holdings Limited, with its mammoth operations in China's off-price retail sector, is gearing up for its annual general meeting (AGM) on December 8, 2026. This is where management and stakeholders will hash out everything from strategic pivots to financial health. Forget shareholder votes this...

Continue Reading

Top 5 Most Recently Viewed Articles

Actinium Pharmaceuticals Faces Class Action Lawsuit for Losses

Updated Category News Views 198

Actinium Pharmaceuticals: A Closer Look at the Lawsuit Recently, a significant class action lawsuit was filed against Actinium Pharmaceuticals, Inc. (NYSE: ATNM). This legal action is vital for investors who have experienced financial losses associated with their investments in Actinium's stock. The lawsuit, initiated by Pomerantz LLP, accuses the company and some of its...

Continue Reading
Uranium Energy Corp Delivers Promising Drill Results at Roughrider

Updated Category News Views 69

Uranium Energy Corp Unveils Outstanding Drilling Results Uranium Energy Corp (NYSE American: UEC) is thrilled to share the latest findings from its active drilling campaign at the Roughrider Project, which have revealed striking high-grade uranium mineralization. A drill hole positioned 850 meters northeast of the central Roughrider deposit has showcased remarkable...

Continue Reading
TME Pharma Presents Promising Glioblastoma Trial Outcomes

Updated Category News Views 159

TME Pharma's Progress in Glioblastoma Treatment TME Pharma N.V. is a clinical-stage biotechnology company dedicated to developing innovative therapies for cancer. Recently, they announced an important oral presentation at a renowned medical congress, showcasing the encouraging results from the NOX-A12 GLORIA Phase 1/2 trial. This study aims to address glioblastoma, a...

Continue Reading
Life Time Champions Expanding Pickleball Facilities Across U.S.

Updated Category News Views 327

Life Time Champions Expanding Pickleball Facilities Across U.S. Life Time (NYSE: LTH) proudly marks World Pickleball Day as the sport continues to gain unprecedented popularity across America. With over 750 permanent pickleball courts established within its athletic country clubs, the organization demonstrates its commitment to being at the forefront of this dynamic...

Continue Reading
Edgewise Therapeutics Shares Breakthrough EDG-7500 Results

Updated Category News Views 305

Edgewise Therapeutics Announces Significant Progress in Hypertrophic Cardiomyopathy Treatment Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a pioneering biopharmaceutical company focused on muscle diseases, has recently disclosed positive outcomes from their Phase 2 CIRRUS-HCM trial studying EDG-7500. This treatment targets hypertrophic cardiomyopathy (HCM), a serious...

Continue Reading